IO Biotech (IOBT) Competitors $1.94 -0.01 (-0.26%) As of 03:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IOBT vs. KMDA, TERN, RGNX, SVRA, TECX, FULC, SLDB, PASG, PRTC, and SNDLShould you be buying IO Biotech stock or one of its competitors? The main competitors of IO Biotech include Kamada (KMDA), Terns Pharmaceuticals (TERN), REGENXBIO (RGNX), Savara (SVRA), Tectonic Therapeutic (TECX), Fulcrum Therapeutics (FULC), Solid Biosciences (SLDB), Passage Bio (PASG), PureTech Health (PRTC), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry. IO Biotech vs. Its Competitors Kamada Terns Pharmaceuticals REGENXBIO Savara Tectonic Therapeutic Fulcrum Therapeutics Solid Biosciences Passage Bio PureTech Health SNDL IO Biotech (NASDAQ:IOBT) and Kamada (NASDAQ:KMDA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings. Do analysts rate IOBT or KMDA? IO Biotech currently has a consensus price target of $9.33, suggesting a potential upside of 379.86%. Kamada has a consensus price target of $13.00, suggesting a potential upside of 64.87%. Given IO Biotech's stronger consensus rating and higher possible upside, equities research analysts plainly believe IO Biotech is more favorable than Kamada.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IO Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Kamada 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do insiders and institutionals believe in IOBT or KMDA? 54.8% of IO Biotech shares are held by institutional investors. Comparatively, 20.4% of Kamada shares are held by institutional investors. 2.3% of IO Biotech shares are held by insiders. Comparatively, 36.1% of Kamada shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is IOBT or KMDA more profitable? Kamada has a net margin of 9.60% compared to IO Biotech's net margin of 0.00%. Kamada's return on equity of 6.31% beat IO Biotech's return on equity.Company Net Margins Return on Equity Return on Assets IO BiotechN/A -162.55% -125.08% Kamada 9.60%6.31%4.43% Does the media refer more to IOBT or KMDA? In the previous week, IO Biotech had 1 more articles in the media than Kamada. MarketBeat recorded 1 mentions for IO Biotech and 0 mentions for Kamada. IO Biotech's average media sentiment score of 0.99 beat Kamada's score of 0.00 indicating that IO Biotech is being referred to more favorably in the media. Company Overall Sentiment IO Biotech Positive Kamada Neutral Which has more volatility & risk, IOBT or KMDA? IO Biotech has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500. Comparatively, Kamada has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Which has preferable valuation & earnings, IOBT or KMDA? Kamada has higher revenue and earnings than IO Biotech. IO Biotech is trading at a lower price-to-earnings ratio than Kamada, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIO BiotechN/AN/A-$95.49M-$1.49-1.31Kamada$160.95M2.82$14.46M$0.2927.19 SummaryKamada beats IO Biotech on 9 of the 15 factors compared between the two stocks. Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IOBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IOBT vs. The Competition Export to ExcelMetricIO BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$128.14M$3.04B$5.66B$9.45BDividend YieldN/A2.49%4.01%4.02%P/E Ratio-1.3121.3528.5520.10Price / SalesN/A275.25417.2988.13Price / CashN/A41.6635.9658.29Price / Book2.748.158.545.79Net Income-$95.49M-$55.10M$3.24B$258.18M7 Day Performance2.91%7.51%4.75%3.80%1 Month Performance49.62%21.60%12.89%14.59%1 Year Performance29.24%6.49%36.03%18.91% IO Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IOBTIO Biotech3.6886 of 5 stars$1.95-0.3%$9.33+379.9%+26.6%$128.14MN/A-1.3130KMDAKamada3.3131 of 5 stars$7.78+0.4%$13.00+67.1%+29.9%$447.39M$167.24M26.83360Gap UpTERNTerns Pharmaceuticals3.6235 of 5 stars$5.11+4.3%$15.63+205.8%-29.7%$446.31MN/A-4.6940RGNXREGENXBIO4.1645 of 5 stars$8.70+0.2%$31.63+263.5%-32.9%$436.39M$83.33M-2.80370Analyst RevisionSVRASavara1.8947 of 5 stars$2.51+5.0%$5.60+123.1%-47.8%$433.83MN/A-5.2320TECXTectonic Therapeutic2.674 of 5 stars$23.12+2.1%$83.60+261.6%+33.5%$431.72MN/A-3.16120Analyst ForecastFULCFulcrum Therapeutics0.5738 of 5 stars$7.90+0.9%$6.29-20.4%-18.0%$426.44M$80M-112.84100Upcoming EarningsSLDBSolid Biosciences3.6584 of 5 stars$5.47+4.0%$15.10+176.1%-28.6%$423.98M$8.09M-1.83100Positive NewsAnalyst ForecastPASGPassage Bio2.2832 of 5 stars$6.79-15.3%$150.00+2,109.1%-67.3%$423.76MN/A-6.66130High Trading VolumePRTCPureTech Health1.9854 of 5 stars$17.56-1.4%$45.00+156.3%-16.8%$421.65M$4.32M0.00100Upcoming EarningsGap DownSNDLSNDL1.4061 of 5 stars$1.58+13.7%$3.63+129.4%-27.8%$415.19M$671.81M-5.452,516High Trading Volume Related Companies and Tools Related Companies Kamada Competitors Terns Pharmaceuticals Competitors REGENXBIO Competitors Savara Competitors Tectonic Therapeutic Competitors Fulcrum Therapeutics Competitors Solid Biosciences Competitors Passage Bio Competitors PureTech Health Competitors SNDL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IOBT) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IO Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
